Mar 09, 2017 21:06 pm UTC| Business
NEW YORK, March 09, 2017 -- At the end of the settlement date of February 28, 2017, short interest in2,345 Nasdaq Global MarketSM securities totaled 7,280,848,100 shares compared with 7,247,866,478 shares in2,351 Global...
LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
Mar 09, 2017 21:06 pm UTC| Business
BURLINGTON, Mass., March 09, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews...
LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
Mar 09, 2017 21:06 pm UTC| Business
BURLINGTON, Mass., March 09, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews...
KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
Mar 09, 2017 21:06 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Recent Clinical Development Regulatory Highlights: Reported Positive Data from Phase 1 Proof-of-Concept Clinical Trial...
KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
Mar 09, 2017 21:06 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Recent Clinical Development Regulatory Highlights: Reported Positive Data from Phase 1 Proof-of-Concept Clinical Trial...
StoneMor Partners L.P. Issues Update on Sales Team Development
Mar 09, 2017 21:05 pm UTC| Business
TREVOSE, Pa., March 09, 2017 -- StoneMor Partners L.P. (NYSE:STON) (“StoneMor” or the “Partnership”) today provided additional data on the ongoing restructuring of its salesforce. Total salespeople within the...
Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 09, 2017 21:05 pm UTC| Business
BOSTON, March 09, 2017 -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases including type 2 diabetes and...